About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT06560073

Intravenous Tranexamic Acid in Diabetic Macular TRD Surgeries

The goal of this observational study is to learn about safety and results of peroperative and intraoperative intravenous Tranexamic acid for diabetic macular tractional detachment eye surgeries . The ...

Lead sponsor: Ahalia Foundation Eye Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Ahalia Foundation Eye Hospital

all Patients who agreed and gave informed consent forsurgery as well as to be included in study were included Patients injected INTRAVENOUS TRANEXAMIC ACID 500 mg diluted to 10 ml with normal saline slowly in immediate preoperative period Accordingly, whenever bleeding was anticipated before removing active taut membranes or when bleeder was noted TXA 0.5 g was added upto maximum of 2 g. In Chronic kidney Disease patients dose was kept as maximum of 1.5 g data analysis pack of microsoft excel will be used for statistical analysis. descriptive statistics will be applied. wherever mean of continuous variables is to be compared among subgroups, unpaired students t test will be used. To find any relationship among continuous variables , pearsons correlation or multiple regression will be used from data analysis pack of microsoft excel.

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Eyes of Diabetic patients having Macular Tractional Retinal detachment confirmed on Indirect Ophthalmoscope or B scan when associated with Vitreous hemorrhage or Optical Coherence Tomography

Exclusion Criteria

•Pregnancy, lactation, Oral Contraceptive use, within 6 months thromboembolic disease ,Underlying cardiac arrhythmia where anticoagulation is indicated ,Seizures Severe liver disease,previous history of variceal bleeding ,Allergic history to Tranexamic acid

Related studies

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)

NCT07296952 · Diabetic Retinopathy (DR)

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

NCT07351786 · Diabetes (DM), Retinopathy, Diabetic, and more

Intraoperative OCT Guidance of Intraocular Surgery II

NCT03713268 · Macular Holes, Epiretinal Membrane, and more

Clinical Applications of Advanced Ophthalmic Imaging

NCT03135327 · Multiple Sclerosis, Dry Eye Syndromes, and more

Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diabetic Retinopathy.

NCT06782997 · Diabetic Retinopathy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 19, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment102

Start dateJan 2021

Last updatedAug 19, 2024

Condition

Diabetic Retinopathy Macular Traction Retinal Detachment

Locations shown

Ahaliafoundation Eye Hospital

Palakkad, Kerala

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 19, 2024Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions